Primary |
Hypertension |
28.6% |
Arrhythmia |
14.3% |
Cardiac Failure Congestive |
14.3% |
Depression |
14.3% |
Immune Thrombocytopenic Purpura |
14.3% |
Product Used For Unknown Indication |
14.3% |
|
Carpal Tunnel Syndrome |
20.0% |
Headache |
20.0% |
Hypothyroidism |
20.0% |
Treatment Noncompliance |
20.0% |
Ventricular Extrasystoles |
20.0% |
|
Secondary |
Drug Use For Unknown Indication |
29.5% |
Product Used For Unknown Indication |
18.0% |
Hypertension |
14.3% |
Cardiac Failure |
6.9% |
Essential Hypertension |
3.2% |
Depression |
3.0% |
Agitation |
2.5% |
Diabetes Mellitus |
2.5% |
Hodgkin's Disease |
2.5% |
Insomnia |
2.5% |
Angina Pectoris |
2.0% |
Atrial Fibrillation |
1.7% |
Dementia Alzheimer's Type |
1.7% |
Myocardial Ischaemia |
1.7% |
Heart Transplant |
1.5% |
Ischaemic Cardiomyopathy |
1.3% |
Type 2 Diabetes Mellitus |
1.3% |
Gastrooesophageal Reflux Disease |
1.2% |
Ill-defined Disorder |
1.2% |
Multiple Drug Overdose Intentional |
1.2% |
|
Osteonecrosis |
9.6% |
Haematoma |
7.4% |
Malaise |
7.4% |
Pierre Robin Syndrome |
6.4% |
Renal Failure |
6.4% |
Pruritus |
5.3% |
Pyrexia |
5.3% |
Thrombocytopenia |
5.3% |
Cytolytic Hepatitis |
4.3% |
Dermatitis Exfoliative |
4.3% |
Fall |
4.3% |
Hyponatraemia |
4.3% |
Jaundice |
4.3% |
Overdose |
4.3% |
Respiratory Distress |
4.3% |
Tonic Clonic Movements |
4.3% |
Cardiogenic Shock |
3.2% |
Hepatitis |
3.2% |
Orthostatic Hypotension |
3.2% |
Pancreatitis Necrotising |
3.2% |
|
Concomitant |
Drug Use For Unknown Indication |
23.4% |
Product Used For Unknown Indication |
17.2% |
Hypertension |
13.7% |
Depression |
4.3% |
Ill-defined Disorder |
4.3% |
Pain |
4.0% |
Rheumatoid Arthritis |
3.4% |
Renal Transplant |
3.1% |
Type 2 Diabetes Mellitus |
2.9% |
Osteoporosis |
2.7% |
Myocardial Infarction |
2.6% |
Atrial Fibrillation |
2.5% |
Hiv Infection |
2.4% |
Hypercholesterolaemia |
2.4% |
Diabetes Mellitus |
2.3% |
Cardiac Disorder |
2.3% |
Multiple Myeloma |
1.9% |
Acute Lymphocytic Leukaemia |
1.7% |
Blood Pressure |
1.5% |
Premedication |
1.3% |
|
Renal Failure Acute |
12.7% |
Weight Decreased |
10.6% |
Vomiting |
6.9% |
Malaise |
6.1% |
Anaemia |
5.3% |
Thrombocytopenia |
4.9% |
Pyrexia |
4.5% |
Cytolytic Hepatitis |
4.1% |
Lung Disorder |
4.1% |
Myocardial Infarction |
4.1% |
Renal Failure |
4.1% |
Urinary Tract Infection |
4.1% |
Vertigo |
4.1% |
Atrial Fibrillation |
3.7% |
International Normalised Ratio Increased |
3.7% |
Pulmonary Embolism |
3.7% |
Somnolence |
3.7% |
Nausea |
3.3% |
Restlessness |
3.3% |
Ventricular Extrasystoles |
3.3% |
|
Interacting |
Hypertension |
26.9% |
Drug Use For Unknown Indication |
11.5% |
Epilepsy |
11.5% |
Fibromyalgia |
11.5% |
Asthma |
3.8% |
Cough |
3.8% |
Depression |
3.8% |
Diabetes Mellitus |
3.8% |
Gastric Disorder |
3.8% |
Grand Mal Convulsion |
3.8% |
Hypercholesterolaemia |
3.8% |
Hypothyroidism |
3.8% |
Parkinson's Disease |
3.8% |
Tachycardia |
3.8% |
|
Nodal Arrhythmia |
33.3% |
Drug Level Decreased |
16.7% |
Orthostatic Hypotension |
16.7% |
Rash |
16.7% |
Varicose Ulceration |
16.7% |
|